The long delay in talking openly about perimenopause points to a broader problem in medicine: women’s health has often been treated as less urgent or less central than other areas of care. Even as modern medicine has made major advances and helped people live longer, that progress has not always translated into equal attention for health issues affecting women in midlife.
Perimenopause, the stage leading up to menopause, has often received limited public discussion compared with other common health concerns. That lack of visibility has helped leave many people without clear information or a strong sense that their experiences deserve serious medical attention. The issue is not only about one life stage, but about how health systems and public conversations decide what matters.
The wider concern is that women’s health was sidelined for years, and the effects of that neglect are still being felt. Greater awareness of perimenopause highlights how gaps in research, care, and everyday conversation can persist even in an era of impressive medical innovation. In that sense, the slow recognition of perimenopause is part of a much larger catch-up effort.
As discussion around perimenopause grows, it also underscores the need to treat women’s health as a core part of medicine rather than a niche subject. The renewed focus suggests that progress in healthcare is not only about new treatments and longer lives, but also about deciding whose health experiences are fully seen and taken seriously.
